Immuneering Corporation (IMRX)
NASDAQ·Healthcare·Biotechnology
$4.39
-4.88%
Mkt Cap $162.63M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$14.33
Range $12.00 – $17.00
Implied Upside
+226.8%
Consensus $14.33 vs current $4.39
NASDAQ·Healthcare·Biotechnology
$4.39
-4.88%
Mkt Cap $162.63M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$14.33
Range $12.00 – $17.00
+226.8%
Consensus $14.33 vs current $4.39